Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

20082,305 citationsJournal Article

Authors

David Cunningham · National Health Service

Naureen Starling · National Health Service

Sheela Rao · National Health Service

Timothy Iveson · National Health Service

M. Nicolson · Aberdeen Royal Infirmary

Fareeda Y. Coxon

Gary Middleton

Francis Daniel ·

Abstract

Capecitabine and oxaliplatin are as effective as fluorouracil and cisplatin, respectively, in patients with previously untreated esophagogastric cancer. (Current Controlled Trials number, ISRCTN51678883 [controlled-trials.com].).

Topics & Keywords

Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Esophageal Cancer Research and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 358, Issue 1, pp. 36-46

DOI: 10.1056/nejmoa073149

Field-Weighted Citation Impact: 113.34